Alaunos Therapeutics, Inc. Common Stock (TCRT)
Alaunos Therapeutics, Inc. (TCRT) is a biotechnology company focused on developing innovative cell therapies, particularly in the field of immuno-oncology. The company specializes in engineering T-cell therapies to target various cancers, aiming to harness the body's immune system for more effective treatments.
Company News
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results. C.H. Robinson Worldwide posted adjusted earnings of 50 cents per share, missing market estimates if 81 cents per share. The company’s quarterly sales came in at $4.20 bi...
With the complete separation of the Consumer Health segment, J&J (JNJ) is now a two-sector company focused on the Pharmaceutical and MedTech fields.
HOUSTON, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (“Alaunos” or the “Company”) (Nasdaq: TCRT), today announced financial results for the second quarter ended June 30, 2023. The Company also announced a strategic reprioritization to focus on its hunTR® TCR discovery platform, wind down its TCR-T Phase 1/2 Library tri...
Penny stocks with unusual options activity. The post 7 Penny Stocks To Watch With Unusual Options Activity, December 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Four of the biotech's top managers reveal they've exercised stock options, and investors are following suit by snapping up shares.